167 related articles for article (PubMed ID: 11536289)
41. Prion-induced neuronal damage--the mechanisms of neuronal destruction in the subacute spongiform encephalopathies.
Giese A; Kretzschmar HA
Curr Top Microbiol Immunol; 2001; 253():203-17. PubMed ID: 11417136
[TBL] [Abstract][Full Text] [Related]
42. Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations.
Jackson GS; Hosszu LL; Power A; Hill AF; Kenney J; Saibil H; Craven CJ; Waltho JP; Clarke AR; Collinge J
Science; 1999 Mar; 283(5409):1935-7. PubMed ID: 10082469
[TBL] [Abstract][Full Text] [Related]
43. Conformational diversity in prion protein variants influences intermolecular beta-sheet formation.
Lee S; Antony L; Hartmann R; Knaus KJ; Surewicz K; Surewicz WK; Yee VC
EMBO J; 2010 Jan; 29(1):251-62. PubMed ID: 19927125
[TBL] [Abstract][Full Text] [Related]
44. Sc237 hamster PrPSc and Sc237-derived mouse PrPSc generated by interspecies in vitro amplification exhibit distinct pathological and biochemical properties in tga20 transgenic mice.
Yoshioka M; Imamura M; Okada H; Shimozaki N; Murayama Y; Yokoyama T; Mohri S
Microbiol Immunol; 2011 May; 55(5):331-40. PubMed ID: 21362027
[TBL] [Abstract][Full Text] [Related]
45. Assembly of natural and recombinant prion protein into fibrils.
Leffers KW; Wille H; Stöhr J; Junger E; Prusiner SB; Riesner D
Biol Chem; 2005 Jun; 386(6):569-80. PubMed ID: 16006244
[TBL] [Abstract][Full Text] [Related]
46. Generation of monoclonal antibody that distinguishes PrPSc from PrPC and neutralizes prion infectivity.
Horiuchi M; Karino A; Furuoka H; Ishiguro N; Kimura K; Shinagawa M
Virology; 2009 Nov; 394(2):200-7. PubMed ID: 19766283
[TBL] [Abstract][Full Text] [Related]
47. Insight into the PrPC-->PrPSc conversion from the structures of antibody-bound ovine prion scrapie-susceptibility variants.
Eghiaian F; Grosclaude J; Lesceu S; Debey P; Doublet B; Tréguer E; Rezaei H; Knossow M
Proc Natl Acad Sci U S A; 2004 Jul; 101(28):10254-9. PubMed ID: 15240887
[TBL] [Abstract][Full Text] [Related]
48. Structure-function aspects of prion proteins.
Daggett V
Curr Opin Biotechnol; 1998 Aug; 9(4):359-65. PubMed ID: 9720262
[TBL] [Abstract][Full Text] [Related]
49. Residue-specific mobility changes in soluble oligomers of the prion protein define regions involved in aggregation.
Glaves JP; Ladner-Keay CL; Bjorndahl TC; Wishart DS; Sykes BD
Biochim Biophys Acta Proteins Proteom; 2018 Sep; 1866(9):982-988. PubMed ID: 29935976
[TBL] [Abstract][Full Text] [Related]
50. Autocatalytic conversion of recombinant prion proteins displays a species barrier.
Baskakov IV
J Biol Chem; 2004 Feb; 279(9):7671-7. PubMed ID: 14668351
[TBL] [Abstract][Full Text] [Related]
51. Preventing misfolding of the prion protein by trimethylamine N-oxide.
Bennion BJ; DeMarco ML; Daggett V
Biochemistry; 2004 Oct; 43(41):12955-63. PubMed ID: 15476389
[TBL] [Abstract][Full Text] [Related]
52. In situ identification of protein structural changes in prion-infected tissue.
Kneipp J; Miller LM; Joncic M; Kittel M; Lasch P; Beekes M; Naumann D
Biochim Biophys Acta; 2003 Nov; 1639(3):152-8. PubMed ID: 14636946
[TBL] [Abstract][Full Text] [Related]
53. Effects of pH and aggregation in the human prion conversion into scrapie form: a study using molecular dynamics with excited normal modes.
Lima AN; de Oliveira RJ; Braz ASK; de Souza Costa MG; Perahia D; Scott LPB
Eur Biophys J; 2018 Jul; 47(5):583-590. PubMed ID: 29546436
[TBL] [Abstract][Full Text] [Related]
54. Abnormalities in stress proteins in prion diseases.
Tatzelt J; Voellmy R; Welch WJ
Cell Mol Neurobiol; 1998 Dec; 18(6):721-9. PubMed ID: 9876878
[TBL] [Abstract][Full Text] [Related]
55. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.
Coleman BM; Harrison CF; Guo B; Masters CL; Barnham KJ; Lawson VA; Hill AF
J Virol; 2014 Mar; 88(5):2690-703. PubMed ID: 24352465
[TBL] [Abstract][Full Text] [Related]
56. Prion propagation and molecular chaperones.
Zahn R
Q Rev Biophys; 1999 Nov; 32(4):309-70. PubMed ID: 11194568
[No Abstract] [Full Text] [Related]
57. Aggregation and fibrillization of the recombinant human prion protein huPrP90-231.
Swietnicki W; Morillas M; Chen SG; Gambetti P; Surewicz WK
Biochemistry; 2000 Jan; 39(2):424-31. PubMed ID: 10631004
[TBL] [Abstract][Full Text] [Related]
58. DNA converts cellular prion protein into the beta-sheet conformation and inhibits prion peptide aggregation.
Cordeiro Y; Machado F; Juliano L; Juliano MA; Brentani RR; Foguel D; Silva JL
J Biol Chem; 2001 Dec; 276(52):49400-9. PubMed ID: 11604397
[TBL] [Abstract][Full Text] [Related]
59. Optimized overproduction, purification, characterization and high-pressure sensitivity of the prion protein in the native (PrP(C)-like) or amyloid (PrP(Sc)-like) conformation.
Alvarez-Martinez MT; Torrent J; Lange R; Verdier JM; Balny C; Liautard JP
Biochim Biophys Acta; 2003 Feb; 1645(2):228-40. PubMed ID: 12573253
[TBL] [Abstract][Full Text] [Related]
60. Loss of functional prion protein: a role in prion disorders?
Borchelt DR; Sisodia SS
Chem Biol; 1996 Aug; 3(8):619-21. PubMed ID: 8807894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
